がん登録ソフトウェアの世界市場:タイプ別(スタンドアロンソフトウェア、統合ソフトウェア)展開モデル別(オンプレミス、クラウドベース)データベースタイプ別(商用データベース、公共データベース)機能別(州および連邦向けがん報告、患者ケア管理、医学研究および臨床研究、製品転帰評価)エンドユーザー別(政府機関および第三者管理者、病院および医療行為、民間企業、製薬、バイオテクノロジー、および医療機器会社、研究センター)

◆英語タイトル:Global Cancer Registry Software Market Size study, by Type (Standalone Software, Integrated Software), by Deployment Model (On-Premise, Cloud-Based), by Database Type (Commercial Database, Public Database), By Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research & Clinical Studies, Product Outcome Evaluation), by End-User (Government Organizations & Third-Party Administrators, Hospitals & Medical Practices, Private Players, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers) and Regional Forecasts 2019-2026
◆商品コード:BZW9NV024
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2019年11月27日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥442,400見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD5,550 ⇒換算¥621,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

世界のがん登録ソフトウェア市場は2018年に約50.68百万米ドルに達し、2019-2026年の予測期間にわたって10.5%以上の成長率で成長すると予想されています。 がん登録はコンピュータ化されたデータベースであり、ソフトウェアソリューションを使用しがん患者のデータを整理、収集、保存しがん特有の結果、状況、および薬物/医療機器の露出を評価します。当調査レポートでは、がん登録ソフトウェアの世界市場について調査・分析し、エグゼクティブサマリー、定義と範囲、動向、タイプ別、展開モデル別分析、データベースタイプ別分析、地域別分析、機能別、エンドユーザー別分析、地域別分析、競合分析、調査プロセスなどを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・がん登録ソフトウェアの世界市場:定義と範囲
・がん登録ソフトウェアの世界市場:動向
・がん登録ソフトウェアの世界市場:タイプ別(スタンドアロンソフトウェア、統合ソフトウェア)
・がん登録ソフトウェアの世界市場:展開モデル別(オンプレミス、クラウドベース)
・がん登録ソフトウェアの世界市場:データベースタイプ別(商用データベース、公共データベース)
・がん登録ソフトウェアの世界市場:機能別(州および連邦向けがん報告、患者ケア管理、医学研究および臨床研究、製品転帰評価)
・がん登録ソフトウェアの世界市場:エンドユーザー別(政府機関および第三者管理者、病院および医療行為、民間企業、製薬、バイオテクノロジー、および医療機器会社、研究センター)
・がん登録ソフトウェアの世界市場:地域別分析
・競合分析
・調査プロセス
【レポートの概要】

Global Cancer Registry Software Market is valued approximately at USD 50.68 million in 2018 and is anticipated to grow with a healthy growth rate of more than 10.5% over the forecast period 2019-2026. Cancer registry is a computerized database which uses software solutions to organize, gather and store data of the cancer patients and evaluate cancer-specific upshots, situations and drug/medical device exposure. Growing number of cancer cases, increasing adoption of EHR, favorable government programs towards cancer and growing use of cancer patient registry data for post-marketing surveillance are the few factors responsible for high CAGR of the market over the forecast period. For instance, In 2018, it was estimated that there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide. The global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040 due to the growth and aging of the population, according to the International Agency for Research on Cancer (IARC). Owing to Tthe prevalence of cancer is on surging trend thereby escalating, the need for cancer registry software is also increased all over the world. Moreover, increasing number of accountable care organizations and growth of cloud-based cancer patient registry solutions is the major factor likely to create lucrative growth opportunity to the market in the upcoming years. However, privacy and data security-related concerns is one of the major factors anticipated to limiting the growth of global cancer registry software market during the forecast period.

The regional analysis of global Cancer Registry Software Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer, government funding initiatives to encourage the development of cancer registries and high investments in healthcare IT across the region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026.
Major market player included in this report are:
Onco, Inc.
C/Net Solutions
Elekta AB (PUB)
Rocky Mountain Cancer Data Systems
Electronic Registry Systems, Inc.
MckessonMcKesson Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Standalone Software
Integrated Software

By Deployment Model:
On-premise
Cloud-Based

By Database Type:
Commercial Database
Public Database

By Functionality:
Cancer Reporting to Meet State and Federal Regulations
Patient Care Management
Medical Research & Clinical Studies
Product Outcome Evaluation

By End-User:
Government Organizations & Third-Party Administrators
Hospitals & Medical Practices
Private Players
Pharmaceutical, Biotechnology, and Medical Device Companies
Research Centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Cancer Registry Software Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
1.2.1. Cancer Registry Software Market, by Type, 2017-2026 (USD Million)
1.2.2. Cancer Registry Software Market, by Deployment Model, 2017-2026 (USD Million)
1.2.3. Cancer Registry Software Market, by Database Type, 2017-2026 (USD Million)
1.2.4. Cancer Registry Software Market, by Functionality, 2017-2026 (USD Million)
1.2.5. Cancer Registry Software Market, by End-User, 2017-2026 (USD Million)
1.2.6. Cancer Registry Software Market, by Region, 2017-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Registry Software Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Registry Software Market Dynamics
3.1. Cancer Registry Software Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cancer Registry Software Market Type Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer Registry Software Market, by Type
5.1. Market Snapshot
5.2. Global Cancer Registry Software Market by Type, Performance – Potential Analysis
5.3. Global Cancer Registry Software Market Estimates & Forecasts by Type 2016-2026 (USD Million)
5.4. Cancer Registry Software Market, Sub Segment Analysis
5.4.1. Standalone Software
5.4.2. Integrated Software
Chapter 6. Global Cancer Registry Software Market, by Deployment Model
6.1. Market Snapshot
6.2. Global Cancer Registry Software Market by Deployment Model, Performance – Potential Analysis
6.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
6.4. Cancer Registry Software Market, Sub Segment Analysis
6.4.1. On-premises
6.4.2. Cloud-based
Chapter 7. Global Cancer Registry Software Market, by Database Type
7.1. Market Snapshot
7.2. Global Cancer Registry Software Market by Deployment Model, Performance – Potential Analysis
7.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
7.3.1. Commercial Databases
7.3.2. Public Databases
Chapter 8. Global Cancer Registry Software Market, by Functionality
8.1. Market Snapshot
8.2. Global Cancer Registry Software Market by Functionality, Performance – Potential Analysis
8.3. Global Cancer Registry Software Market Estimates & Forecasts by Functionality, 2016-2026 (USD Million)
8.3.1. Cancer Reporting to Meet State and Federal Regulations
8.3.2. Patient Care Management
8.3.3. Medical Research & Clinical Studies
8.3.4. Product Outcome Evaluation
Chapter 9. Global Cancer Registry Software Market, by End-User
9.1. Market Snapshot
9.2. Global Cancer Registry Software Market by Deployment Model, Performance – Potential Analysis
9.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model, 2016-2026 (USD Million)
9.3.1. Government Organizations & Third-Party Administrators
9.3.2. Hospitals & Medical Practices
9.3.3. Private Payers
9.3.4. Pharmaceutical, Biotechnology, and Medical Device Companies
9.3.5. Research Centers
Chapter 10. Global Cancer Registry Software Market, Regional Analysis
10.1. Cancer Registry Software Market, Regional Market Snapshot
10.2. North America Cancer Registry Software Market
10.2.1. U.S. Cancer Registry Software Market
10.2.1.1. Type breakdown estimates & forecasts, 2016-2026
10.2.1.2. Deployment Model breakdown estimates & forecasts, 2016-2026
10.2.1.3. Database Type breakdown estimates & forecasts, 2016-2026
10.2.1.4. Functionality breakdown estimates & forecasts, 2016-2026
10.2.1.5. End-User breakdown estimates & forecasts, 2016-2026
10.2.2. Canada Cancer Registry Software Market
10.3. Europe Cancer Registry Software Market Snapshot
10.3.1. U.K. Cancer Registry Software Market
10.3.2. Rest of Europe Cancer Registry Software Market
10.4. Asia-Pacific Cancer Registry Software Market Snapshot
10.4.1. China Cancer Registry Software Market
10.4.2. India Cancer Registry Software Market
10.4.3. Japan Cancer Registry Software Market
10.4.4. Rest of Asia Pacific Cancer Registry Software Market
10.5. Latin America Cancer Registry Software Market Snapshot
10.5.1. Brazil Cancer Registry Software Market
10.5.2. Mexico Cancer Registry Software Market
10.6. Rest of The World Cancer Registry Software Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Onco, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject To Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. C/Net Solutions
11.2.3. Elekta AB (PUB)
11.2.4. Rocky Mountain Cancer Data Systems
11.2.5. Electronic Registry Systems, Inc.
11.2.6. Mckesson Corporation
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CANCER REGISTRY SOFTWARE MARKET
TABLE 3. GLOBAL CANCER REGISTRY SOFTWARE MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD MILLION)
TABLE 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DEPLOYMENT MODEL 2016-2026 (USD MILLION)
TABLE 9. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY DATABASE TYPE 2016-2026 (USD MILLION)
TABLE 10. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY FUNCTIONALITY 2016-2026 (USD MILLION)
TABLE 11. GLOBAL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)
TABLE 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 22. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 23. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 25. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 26. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 28. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 29. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 31. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 32. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 34. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 35. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 37. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 38. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 40. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 41. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 42. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. U.S. CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 45. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 46. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 48. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 49. CANADA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 51. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 54. UK CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 56. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 57. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 59. GERMANY CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 60. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 61. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 62. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 63. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 64. ROE CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 65. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 66. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 67. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 68. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 69. CHINA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 70. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 71. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 72. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 73. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 74. INDIA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 75. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 76. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 77. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 78. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 79. JAPAN CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 80. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 81. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 82. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 83. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 84. ROAPAC CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 85. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 86. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 87. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 88. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 89. BRAZIL CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 90. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 91. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 92. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 93. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 94. MEXICO CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 95. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 96. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 97. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 98. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 99. ROLA CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 100. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 101. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 102. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 103. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 104. ROW CANCER REGISTRY SOFTWARE MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)


FIG 1. GLOBAL CANCER REGISTRY SOFTWARE MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL CANCER REGISTRY SOFTWARE MARKET, MARKET ESTIMATION BUILDING TYPES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL CANCER REGISTRY SOFTWARE MARKET, KEY TRENDS 2018
FIG 5. GLOBAL CANCER REGISTRY SOFTWARE MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL CANCER REGISTRY SOFTWARE MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL CANCER REGISTRY SOFTWARE MARKET, PEST ANALYSIS
FIG 8. GLOBAL CANCER REGISTRY SOFTWARE MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 15. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 16. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 17. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 18. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 19. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 20. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 21. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 22. GLOBAL CANCER REGISTRY SOFTWARE MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 23. GLOBAL CANCER REGISTRY SOFTWARE MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 24. NORTH AMERICA CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
FIG 25. EUROPE CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
FIG 26. ASIA PACIFIC CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
FIG 27. LATIN AMERICA CANCER REGISTRY SOFTWARE MARKET 2016 & 2026 (USD MILLION)
FIG 28. GLOBAL CANCER REGISTRY SOFTWARE MARKET, COMPANY MARKET SHARE ANALYSIS (2018)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[がん登録ソフトウェアの世界市場:タイプ別(スタンドアロンソフトウェア、統合ソフトウェア)展開モデル別(オンプレミス、クラウドベース)データベースタイプ別(商用データベース、公共データベース)機能別(州および連邦向けがん報告、患者ケア管理、医学研究および臨床研究、製品転帰評価)エンドユーザー別(政府機関および第三者管理者、病院および医療行為、民間企業、製薬、バイオテクノロジー、および医療機器会社、研究センター)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆